𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course

✍ Scribed by Marcus Bahra; UIF P. Neumann; Dietmar Jacob; Gero Puhl; Jochen Klupp; Jan M. Langrehr; Thomas Berg; Peter Neuhaus


Book ID
114803335
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
88 KB
Volume
5
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term antiviral therapy for recurren
✍ Thomas Walter; Jean-Yves Scoazec; Olivier Guillaud; ValΓ©rie Hervieu; Philippe Ch πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 251 KB πŸ‘ 1 views

More than 50% of patients with a recurrent posttransplant hepatitis C virus infection fail to respond to antiviral treatment. The aim of this study was to evaluate the interest of a long-term antiviral treatment maintained for more than 48 weeks. Seventy treated patients, with a histological follow-

Histologic recurrence of chronic hepatit
✍ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We